enVVeno Medical Corporation (NVNO) analyst actions
Rating and price-target actions on NVNO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NVNO overview →
2 measured NVNO analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| enVVeno Medical Reports First Quarter 2025 Financial Results and Reiterates Progress Toward VenoValve FDA Decision Expected in 2H24 | Press release | +2.66% | +9.97% | |
| enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R) | Press release | -0.30% | +1.47% |
Keep exploring
More NVNO: earnings → · SEC filings → · NVNO overview →